1. Home
  2. CRDL vs RVSB Comparison

CRDL vs RVSB Comparison

Compare CRDL & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDL
  • RVSB
  • Stock Information
  • Founded
  • CRDL 2017
  • RVSB 1923
  • Country
  • CRDL Canada
  • RVSB United States
  • Employees
  • CRDL N/A
  • RVSB N/A
  • Industry
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • RVSB Savings Institutions
  • Sector
  • CRDL Health Care
  • RVSB Finance
  • Exchange
  • CRDL Nasdaq
  • RVSB Nasdaq
  • Market Cap
  • CRDL 102.0M
  • RVSB 120.0M
  • IPO Year
  • CRDL N/A
  • RVSB 1993
  • Fundamental
  • Price
  • CRDL $1.03
  • RVSB $5.96
  • Analyst Decision
  • CRDL Strong Buy
  • RVSB
  • Analyst Count
  • CRDL 3
  • RVSB 0
  • Target Price
  • CRDL $9.00
  • RVSB N/A
  • AVG Volume (30 Days)
  • CRDL 226.1K
  • RVSB 70.7K
  • Earning Date
  • CRDL 05-13-2025
  • RVSB 04-28-2025
  • Dividend Yield
  • CRDL N/A
  • RVSB 1.41%
  • EPS Growth
  • CRDL N/A
  • RVSB N/A
  • EPS
  • CRDL N/A
  • RVSB 0.04
  • Revenue
  • CRDL N/A
  • RVSB $46,646,000.00
  • Revenue This Year
  • CRDL N/A
  • RVSB $4.26
  • Revenue Next Year
  • CRDL N/A
  • RVSB $8.70
  • P/E Ratio
  • CRDL N/A
  • RVSB $152.21
  • Revenue Growth
  • CRDL N/A
  • RVSB N/A
  • 52 Week Low
  • CRDL $0.77
  • RVSB $3.30
  • 52 Week High
  • CRDL $3.12
  • RVSB $6.38
  • Technical
  • Relative Strength Index (RSI)
  • CRDL 50.17
  • RVSB 62.88
  • Support Level
  • CRDL $0.92
  • RVSB $5.68
  • Resistance Level
  • CRDL $1.08
  • RVSB $5.80
  • Average True Range (ATR)
  • CRDL 0.11
  • RVSB 0.18
  • MACD
  • CRDL 0.02
  • RVSB -0.00
  • Stochastic Oscillator
  • CRDL 72.64
  • RVSB 75.78

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: